MedPath

Sodium Ferric Gluconate Complex in Sucrose

These highlights do not include all the information needed to use sodium ferric gluconate complex in sucrose injection safely and effectively. See full prescribing information for sodium ferric gluconate complex in sucrose injection. Sodium ferric gluconate complex in sucrose injection, for intravenous use Initial U.S. Approval: 1999

Approved
Approval ID

218d1b8d-b24f-4f77-b588-97c7dd1c2eec

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 1, 2022

Manufacturers
FDA

Hikma Pharmaceuticals USA Inc.

DUNS: 001230762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Ferric Gluconate Complex in Sucrose

PRODUCT DETAILS

NDC Product Code0143-9570
Application NumberANDA078215
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJuly 1, 2022
Generic NameSodium Ferric Gluconate Complex in Sucrose

INGREDIENTS (4)

SODIUM FERRIC GLUCONATE COMPLEXActive
Quantity: 12.5 mg in 1 mL
Code: CC9149U2QX
Classification: ACTIM
SUCROSEInactive
Quantity: 195 mg in 1 mL
Code: C151H8M554
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 9 mg in 1 mL
Code: LKG8494WBH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Ferric Gluconate Complex in Sucrose - FDA Drug Approval Details